4β-hydroxycholesterol is a pro-lipogenic factor that promotes SREBP1c expression and activity through Liver X-receptor
Ofer Moldavski(Icahn School of Medicine at Mount Sinai), Roberto Zoncu(University of California, Berkeley), Charles A. Berdan(University of California, Berkeley), Daniel K. Nomura(Berkeley College), Robert J. van Eijkeren(University of California, Berkeley), Peter‐James H. Zushin(University of California, Berkeley), Ethan J. Weiss(University of California, San Francisco), Douglas F. Covey(Washington University in St. Louis), Xuntian Jiang(Washington University in St. Louis), Mingxing Qian(Washington University in St. Louis), Andreas Stahl(University of California, Berkeley), Daniel S. Ory(Washington University in St. Louis)
Cited by 0
Related Papers
Advances in covalent drug discovery
|Nature Reviews Drug Discovery|2022|757
Transgenic Expression of Fatty Acid Transport Protein 1 in the Heart Causes Lipotoxic Cardiomyopathy
|Circulation Research|2004|468
Deubiquitinase-targeting chimeras for targeted protein stabilization
|Nature Chemical Biology|2022|310
An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ
|Nature|2014|291